Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 49.6
4.62 %
$ 9.21 B
Market Cap
-8.87
P/E
Price Target
Average
55.39%
Revenue Forecast
Estimate
10.86%
EBIT
Estimate
--2.10%
Net Income
Estimate
21.61%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exact Sciences Corporation
Wall Street analysts predict an average 1-year price target for EXAS of $77.1 , with forecasts ranging from
a
low of
$65 to a high of $95 .
EXAS Lowest Price Target
Wall Street Target
65 USD
31.05%
EXAS Average Price Target
Wall Street Target
77.1 USD
55.39%
EXAS Highest Price Target
Wall Street Target
95 USD
91.53%
REVENUE FORECAST
Revenue Forecast Chart EXAS
EBIT FORECAST
EBIT Forecast Chart EXAS
NET INCOME FORECAST
Net Income Chart EXAS